Submitted by kBLASTER Team on
by Varun Saxena for Fierce Medical Devices
Commentary on FDA's final guidance titled The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notification [510(k)] which states a single primary predicate is needed for a 510(k) submission
